De Novo Acquisition of Resistance to SCY-078 in Candida glabrata Involves FKS Mutations That both Overlap and Are Distinct from Those Conferring Echinocandin Resistance.

Abstract:

:SCY-078 is an orally active antifungal whose target is the β-(1,3)-d-glucan synthase (GS). We evaluated the spontaneous emergence of SCY-078-resistant Candida glabrata isolates following drug exposure in vitro Resistant isolates were analyzed using broth microdilution methodology and FKS sequencing. The kinetic inhibition parameter IC50 (50% inhibitory concentration) was also determined from GS complexes. The spectrum of resistance mutations found suggested a partially overlapping but independent binding site for SCY-078 relative to echinocandins on GS.

authors

Jiménez-Ortigosa C,Perez WB,Angulo D,Borroto-Esoda K,Perlin DS

doi

10.1128/AAC.00833-17

subject

Has Abstract

pub_date

2017-08-24 00:00:00

issue

9

eissn

0066-4804

issn

1098-6596

pii

AAC.00833-17

journal_volume

61

pub_type

杂志文章